![Johan Strömqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Johan Strömqvist
Directeur/Membre du Conseil chez
NEWBURY PHARMACEUTICALS AB
Profil
Johan Strömqvist is the founder of Single Technologies AB, holding the title of Chief Executive Officer & Director since 2014.
Dr. Strömqvist is currently an Independent Director at Newbury Pharmaceuticals AB since 2020.
Education includes a graduate degree from the University of Stockholm and both a graduate and a doctorate degree from the Royal Institute of Technology.
Postes actifs de Johan Strömqvist
| Sociétés | Poste | Début |
|---|---|---|
| NEWBURY PHARMACEUTICALS AB | Directeur/Membre du Conseil | 01/01/2020 |
Single Technologies AB
 Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Develops 3-D sequencing technology | Fondateur | 01/01/2014 |
Formation de Johan Strömqvist
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Single Technologies AB
Single Technologies AB Miscellaneous Commercial ServicesCommercial Services Develops 3-D sequencing technology | Commercial Services |
Newbury Pharmaceuticals AB
 Newbury Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a hybrid pharmaceutical company | Health Technology |
Choisissez Zonebourse 
